Format

Send to

Choose Destination
Emerg Infect Dis. 2013 Jun;19(6):870-8. doi: 10.3201/eid1906.121515.

New Delhi metallo-β-lactamase-producing Enterobacteriaceae, United States.

Author information

1
Antimicrobial Resistance and Characterization Laboratory, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop G08, Atlanta, GA 30329, USA. jkr1@cdc.gov

Abstract

We characterized 9 New Delhi metallo-β-lactamase-producing Enterobacteriaceae (5 Klebsiella pneumoniae, 2 Escherichia coli, 1 Enterobacter cloacae, 1 Salmonella enterica serovar Senftenberg) isolates identified in the United States and cultured from 8 patients in 5 states during April 2009-March 2011. Isolates were resistant to β-lactams, fluoroquinolones, and aminoglycosides, demonstrated MICs ≤1 µg/mL of colistin and polymyxin, and yielded positive metallo-β-lactamase screening results. Eight isolates had blaNDM-1, and 1 isolate had a novel allele (blaNDM-6). All 8 patients had recently been in India or Pakistan, where 6 received inpatient health care. Plasmids carrying blaNDM frequently carried AmpC or extended spectrum β-lactamase genes. Two K. pneumoniae isolates and a K. pneumoniae isolate from Sweden shared incompatibility group A/C plasmids with indistinguishable restriction patterns and a common blaNDM fragment; all 3 were multilocus sequence type 14. Restriction profiles of the remaining New Delhi metallo-β-lactamase plasmids, including 2 from the same patient, were diverse.

KEYWORDS:

Enterobacteriaceae; NDM; New Delhi metallo-β-lactamase; United States; antimicrobial resistance; bacteria; carbapenem resistance; carbapenemase

PMID:
23731823
PMCID:
PMC3713825
DOI:
10.3201/eid1906.121515
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for CDC-NCEZID Icon for PubMed Central
Loading ...
Support Center